Global Neoantigen Vaccine Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neoantigen Vaccine Market Size 2017-2028

2.1.2 Neoantigen Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neoantigen Vaccine Segment by Type

2.2.1 Personalized Vaccine

2.2.2 Off-the shelf Vaccine

2.3 Neoantigen Vaccine Market Size by Type

2.3.1 Neoantigen Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

2.4 Neoantigen Vaccine Segment by Application

2.4.1 Lung Cancer

2.4.2 Melanoma Cancer

2.4.3 Gastrointestinal Cancer

2.4.4 Brain Cancer

2.4.5 Others

2.5 Neoantigen Vaccine Market Size by Application

2.5.1 Neoantigen Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

3 Neoantigen Vaccine Market Size by Player

3.1 Neoantigen Vaccine Market Size Market Share by Players

3.1.1 Global Neoantigen Vaccine Revenue by Players (2020-2022)

3.1.2 Global Neoantigen Vaccine Revenue Market Share by Players (2020-2022)

3.2 Global Neoantigen Vaccine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neoantigen Vaccine by Regions

4.1 Neoantigen Vaccine Market Size by Regions (2017-2022)

4.2 Americas Neoantigen Vaccine Market Size Growth (2017-2022)

4.3 APAC Neoantigen Vaccine Market Size Growth (2017-2022)

4.4 Europe Neoantigen Vaccine Market Size Growth (2017-2022)

4.5 Middle East & Africa Neoantigen Vaccine Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neoantigen Vaccine Market Size by Country (2017-2022)

5.2 Americas Neoantigen Vaccine Market Size by Type (2017-2022)

5.3 Americas Neoantigen Vaccine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neoantigen Vaccine Market Size by Region (2017-2022)

6.2 APAC Neoantigen Vaccine Market Size by Type (2017-2022)

6.3 APAC Neoantigen Vaccine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neoantigen Vaccine by Country (2017-2022)

7.2 Europe Neoantigen Vaccine Market Size by Type (2017-2022)

7.3 Europe Neoantigen Vaccine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neoantigen Vaccine by Region (2017-2022)

8.2 Middle East & Africa Neoantigen Vaccine Market Size by Type (2017-2022)

8.3 Middle East & Africa Neoantigen Vaccine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neoantigen Vaccine Market Forecast

10.1 Global Neoantigen Vaccine Forecast by Regions (2023-2028)

10.1.1 Global Neoantigen Vaccine Forecast by Regions (2023-2028)

10.1.2 Americas Neoantigen Vaccine Forecast

10.1.3 APAC Neoantigen Vaccine Forecast

10.1.4 Europe Neoantigen Vaccine Forecast

10.1.5 Middle East & Africa Neoantigen Vaccine Forecast

10.2 Americas Neoantigen Vaccine Forecast by Country (2023-2028)

10.2.1 United States Neoantigen Vaccine Market Forecast

10.2.2 Canada Neoantigen Vaccine Market Forecast

10.2.3 Mexico Neoantigen Vaccine Market Forecast

10.2.4 Brazil Neoantigen Vaccine Market Forecast

10.3 APAC Neoantigen Vaccine Forecast by Region (2023-2028)

10.3.1 China Neoantigen Vaccine Market Forecast

10.3.2 Japan Neoantigen Vaccine Market Forecast

10.3.3 Korea Neoantigen Vaccine Market Forecast

10.3.4 Southeast Asia Neoantigen Vaccine Market Forecast

10.3.5 India Neoantigen Vaccine Market Forecast

10.3.6 Australia Neoantigen Vaccine Market Forecast

10.4 Europe Neoantigen Vaccine Forecast by Country (2023-2028)

10.4.1 Germany Neoantigen Vaccine Market Forecast

10.4.2 France Neoantigen Vaccine Market Forecast

10.4.3 UK Neoantigen Vaccine Market Forecast

10.4.4 Italy Neoantigen Vaccine Market Forecast

10.4.5 Russia Neoantigen Vaccine Market Forecast

10.5 Middle East & Africa Neoantigen Vaccine Forecast by Region (2023-2028)

10.5.1 Egypt Neoantigen Vaccine Market Forecast

10.5.2 South Africa Neoantigen Vaccine Market Forecast

10.5.3 Israel Neoantigen Vaccine Market Forecast

10.5.4 Turkey Neoantigen Vaccine Market Forecast

10.5.5 GCC Countries Neoantigen Vaccine Market Forecast

10.6 Global Neoantigen Vaccine Forecast by Type (2023-2028)

10.7 Global Neoantigen Vaccine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Neoantigen Vaccine Product Offered

11.1.3 Pfizer Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Merck & Co Inc

11.2.1 Merck & Co Inc Company Information

11.2.2 Merck & Co Inc Neoantigen Vaccine Product Offered

11.2.3 Merck & Co Inc Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck & Co Inc Main Business Overview

11.2.5 Merck & Co Inc Latest Developments

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Information

11.3.2 Eli Lilly and Company Neoantigen Vaccine Product Offered

11.3.3 Eli Lilly and Company Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Eli Lilly and Company Main Business Overview

11.3.5 Eli Lilly and Company Latest Developments

11.4 BioNTech

11.4.1 BioNTech Company Information

11.4.2 BioNTech Neoantigen Vaccine Product Offered

11.4.3 BioNTech Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BioNTech Main Business Overview

11.4.5 BioNTech Latest Developments

11.5 Roche Holding AG

11.5.1 Roche Holding AG Company Information

11.5.2 Roche Holding AG Neoantigen Vaccine Product Offered

11.5.3 Roche Holding AG Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Roche Holding AG Main Business Overview

11.5.5 Roche Holding AG Latest Developments

11.6 OSE Immunotherapeutics

11.6.1 OSE Immunotherapeutics Company Information

11.6.2 OSE Immunotherapeutics Neoantigen Vaccine Product Offered

11.6.3 OSE Immunotherapeutics Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 OSE Immunotherapeutics Main Business Overview

11.6.5 OSE Immunotherapeutics Latest Developments

11.7 Gritstone Bio

11.7.1 Gritstone Bio Company Information

11.7.2 Gritstone Bio Neoantigen Vaccine Product Offered

11.7.3 Gritstone Bio Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Gritstone Bio Main Business Overview

11.7.5 Gritstone Bio Latest Developments

11.8 Moderna

11.8.1 Moderna Company Information

11.8.2 Moderna Neoantigen Vaccine Product Offered

11.8.3 Moderna Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Moderna Main Business Overview

11.8.5 Moderna Latest Developments

11.9 Avidea Technologies

11.9.1 Avidea Technologies Company Information

11.9.2 Avidea Technologies Neoantigen Vaccine Product Offered

11.9.3 Avidea Technologies Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Avidea Technologies Main Business Overview

11.9.5 Avidea Technologies Latest Developments

11.10 Vaccibody AS

11.10.1 Vaccibody AS Company Information

11.10.2 Vaccibody AS Neoantigen Vaccine Product Offered

11.10.3 Vaccibody AS Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Vaccibody AS Main Business Overview

11.10.5 Vaccibody AS Latest Developments

11.11 Agenus Inc

11.11.1 Agenus Inc Company Information

11.11.2 Agenus Inc Neoantigen Vaccine Product Offered

11.11.3 Agenus Inc Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Agenus Inc Main Business Overview

11.11.5 Agenus Inc Latest Developments

11.12 Novogene

11.12.1 Novogene Company Information

11.12.2 Novogene Neoantigen Vaccine Product Offered

11.12.3 Novogene Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Novogene Main Business Overview

11.12.5 Novogene Latest Developments

11.13 ZIOPHARM Oncology

11.13.1 ZIOPHARM Oncology Company Information

11.13.2 ZIOPHARM Oncology Neoantigen Vaccine Product Offered

11.13.3 ZIOPHARM Oncology Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 ZIOPHARM Oncology Main Business Overview

11.13.5 ZIOPHARM Oncology Latest Developments

11.14 ISA Pharmaceuticals

11.14.1 ISA Pharmaceuticals Company Information

11.14.2 ISA Pharmaceuticals Neoantigen Vaccine Product Offered

11.14.3 ISA Pharmaceuticals Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 ISA Pharmaceuticals Main Business Overview

11.14.5 ISA Pharmaceuticals Latest Developments

11.15 BrightPath Biotherapeutics

11.15.1 BrightPath Biotherapeutics Company Information

11.15.2 BrightPath Biotherapeutics Neoantigen Vaccine Product Offered

11.15.3 BrightPath Biotherapeutics Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 BrightPath Biotherapeutics Main Business Overview

11.15.5 BrightPath Biotherapeutics Latest Developments

11.16 Vaximm AG

11.16.1 Vaximm AG Company Information

11.16.2 Vaximm AG Neoantigen Vaccine Product Offered

11.16.3 Vaximm AG Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Vaximm AG Main Business Overview

11.16.5 Vaximm AG Latest Developments

11.17 Medigene AG

11.17.1 Medigene AG Company Information

11.17.2 Medigene AG Neoantigen Vaccine Product Offered

11.17.3 Medigene AG Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Medigene AG Main Business Overview

11.17.5 Medigene AG Latest Developments

11.18 Genocea Biosciences Inc

11.18.1 Genocea Biosciences Inc Company Information

11.18.2 Genocea Biosciences Inc Neoantigen Vaccine Product Offered

11.18.3 Genocea Biosciences Inc Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Genocea Biosciences Inc Main Business Overview

11.18.5 Genocea Biosciences Inc Latest Developments

11.19 Advaxis

11.19.1 Advaxis Company Information

11.19.2 Advaxis Neoantigen Vaccine Product Offered

11.19.3 Advaxis Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Advaxis Main Business Overview

11.19.5 Advaxis Latest Developments

11.20 Nouscom

11.20.1 Nouscom Company Information

11.20.2 Nouscom Neoantigen Vaccine Product Offered

11.20.3 Nouscom Neoantigen Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Nouscom Main Business Overview

11.20.5 Nouscom Latest Developments

12 Research Findings and Conclusion

Table 1. Neoantigen Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Personalized Vaccine

Table 3. Major Players of Off-the shelf Vaccine

Table 4. Neoantigen Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Neoantigen Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

Table 7. Neoantigen Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Neoantigen Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

Table 10. Global Neoantigen Vaccine Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Neoantigen Vaccine Revenue Market Share by Player (2020-2022)

Table 12. Neoantigen Vaccine Key Players Head office and Products Offered

Table 13. Neoantigen Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Neoantigen Vaccine Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Neoantigen Vaccine Market Size Market Share by Regions (2017-2022)

Table 18. Americas Neoantigen Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Neoantigen Vaccine Market Size Market Share by Country (2017-2022)

Table 20. Americas Neoantigen Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

Table 22. Americas Neoantigen Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

Table 24. APAC Neoantigen Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Neoantigen Vaccine Market Size Market Share by Region (2017-2022)

Table 26. APAC Neoantigen Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

Table 28. APAC Neoantigen Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

Table 30. Europe Neoantigen Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Neoantigen Vaccine Market Size Market Share by Country (2017-2022)

Table 32. Europe Neoantigen Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

Table 34. Europe Neoantigen Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Neoantigen Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Neoantigen Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Neoantigen Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Neoantigen Vaccine

Table 43. Key Market Challenges & Risks of Neoantigen Vaccine

Table 44. Key Industry Trends of Neoantigen Vaccine

Table 45. Global Neoantigen Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Neoantigen Vaccine Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Neoantigen Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Neoantigen Vaccine Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Neoantigen Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Neoantigen Vaccine Market Size Market Share Forecast by Application (2023-2028)

Table 51. Pfizer Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 52. Pfizer Neoantigen Vaccine Product Offered

Table 53. Pfizer Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Pfizer Main Business

Table 55. Pfizer Latest Developments

Table 56. Merck & Co Inc Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 57. Merck & Co Inc Neoantigen Vaccine Product Offered

Table 58. Merck & Co Inc Main Business

Table 59. Merck & Co Inc Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Merck & Co Inc Latest Developments

Table 61. Eli Lilly and Company Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 62. Eli Lilly and Company Neoantigen Vaccine Product Offered

Table 63. Eli Lilly and Company Main Business

Table 64. Eli Lilly and Company Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Eli Lilly and Company Latest Developments

Table 66. BioNTech Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 67. BioNTech Neoantigen Vaccine Product Offered

Table 68. BioNTech Main Business

Table 69. BioNTech Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. BioNTech Latest Developments

Table 71. Roche Holding AG Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 72. Roche Holding AG Neoantigen Vaccine Product Offered

Table 73. Roche Holding AG Main Business

Table 74. Roche Holding AG Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Roche Holding AG Latest Developments

Table 76. OSE Immunotherapeutics Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 77. OSE Immunotherapeutics Neoantigen Vaccine Product Offered

Table 78. OSE Immunotherapeutics Main Business

Table 79. OSE Immunotherapeutics Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. OSE Immunotherapeutics Latest Developments

Table 81. Gritstone Bio Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 82. Gritstone Bio Neoantigen Vaccine Product Offered

Table 83. Gritstone Bio Main Business

Table 84. Gritstone Bio Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Gritstone Bio Latest Developments

Table 86. Moderna Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 87. Moderna Neoantigen Vaccine Product Offered

Table 88. Moderna Main Business

Table 89. Moderna Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Moderna Latest Developments

Table 91. Avidea Technologies Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 92. Avidea Technologies Neoantigen Vaccine Product Offered

Table 93. Avidea Technologies Main Business

Table 94. Avidea Technologies Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Avidea Technologies Latest Developments

Table 96. Vaccibody AS Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 97. Vaccibody AS Neoantigen Vaccine Product Offered

Table 98. Vaccibody AS Main Business

Table 99. Vaccibody AS Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Vaccibody AS Latest Developments

Table 101. Agenus Inc Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 102. Agenus Inc Neoantigen Vaccine Product Offered

Table 103. Agenus Inc Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Agenus Inc Main Business

Table 105. Agenus Inc Latest Developments

Table 106. Novogene Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 107. Novogene Neoantigen Vaccine Product Offered

Table 108. Novogene Main Business

Table 109. Novogene Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Novogene Latest Developments

Table 111. ZIOPHARM Oncology Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 112. ZIOPHARM Oncology Neoantigen Vaccine Product Offered

Table 113. ZIOPHARM Oncology Main Business

Table 114. ZIOPHARM Oncology Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. ZIOPHARM Oncology Latest Developments

Table 116. ISA Pharmaceuticals Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 117. ISA Pharmaceuticals Neoantigen Vaccine Product Offered

Table 118. ISA Pharmaceuticals Main Business

Table 119. ISA Pharmaceuticals Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. ISA Pharmaceuticals Latest Developments

Table 121. BrightPath Biotherapeutics Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 122. BrightPath Biotherapeutics Neoantigen Vaccine Product Offered

Table 123. BrightPath Biotherapeutics Main Business

Table 124. BrightPath Biotherapeutics Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. BrightPath Biotherapeutics Latest Developments

Table 126. Vaximm AG Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 127. Vaximm AG Neoantigen Vaccine Product Offered

Table 128. Vaximm AG Main Business

Table 129. Vaximm AG Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Vaximm AG Latest Developments

Table 131. Medigene AG Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 132. Medigene AG Neoantigen Vaccine Product Offered

Table 133. Medigene AG Main Business

Table 134. Medigene AG Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Medigene AG Latest Developments

Table 136. Genocea Biosciences Inc Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 137. Genocea Biosciences Inc Neoantigen Vaccine Product Offered

Table 138. Genocea Biosciences Inc Main Business

Table 139. Genocea Biosciences Inc Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Genocea Biosciences Inc Latest Developments

Table 141. Advaxis Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 142. Advaxis Neoantigen Vaccine Product Offered

Table 143. Advaxis Main Business

Table 144. Advaxis Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Advaxis Latest Developments

Table 146. Nouscom Details, Company Type, Neoantigen Vaccine Area Served and Its Competitors

Table 147. Nouscom Neoantigen Vaccine Product Offered

Table 148. Nouscom Main Business

Table 149. Nouscom Neoantigen Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. Nouscom Latest Developments

List of Figures

Figure 1. Neoantigen Vaccine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neoantigen Vaccine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neoantigen Vaccine Market Size Market Share by Type in 2021

Figure 7. Neoantigen Vaccine in Lung Cancer

Figure 8. Global Neoantigen Vaccine Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 9. Neoantigen Vaccine in Melanoma Cancer

Figure 10. Global Neoantigen Vaccine Market: Melanoma Cancer (2017-2022) & ($ Millions)

Figure 11. Neoantigen Vaccine in Gastrointestinal Cancer

Figure 12. Global Neoantigen Vaccine Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)

Figure 13. Neoantigen Vaccine in Brain Cancer

Figure 14. Global Neoantigen Vaccine Market: Brain Cancer (2017-2022) & ($ Millions)

Figure 15. Neoantigen Vaccine in Others

Figure 16. Global Neoantigen Vaccine Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Neoantigen Vaccine Market Size Market Share by Application in 2021

Figure 18. Global Neoantigen Vaccine Revenue Market Share by Player in 2021

Figure 19. Global Neoantigen Vaccine Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Neoantigen Vaccine Market Size 2017-2022 ($ Millions)

Figure 21. APAC Neoantigen Vaccine Market Size 2017-2022 ($ Millions)

Figure 22. Europe Neoantigen Vaccine Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Neoantigen Vaccine Market Size 2017-2022 ($ Millions)

Figure 24. Americas Neoantigen Vaccine Value Market Share by Country in 2021

Figure 25. Americas Neoantigen Vaccine Consumption Market Share by Type in 2021

Figure 26. Americas Neoantigen Vaccine Market Size Market Share by Application in 2021

Figure 27. United States Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Neoantigen Vaccine Market Size Market Share by Region in 2021

Figure 32. APAC Neoantigen Vaccine Market Size Market Share by Application in 2021

Figure 33. China Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Neoantigen Vaccine Market Size Market Share by Country in 2021

Figure 40. Europe Neoantigen Vaccine Market Size Market Share by Type in 2021

Figure 41. Europe Neoantigen Vaccine Market Size Market Share by Application in 2021

Figure 42. Germany Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Neoantigen Vaccine Market Size Market Share by Application in 2021

Figure 50. Egypt Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Neoantigen Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 56. APAC Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 57. Europe Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 59. United States Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 60. Canada Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 63. China Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 64. Japan Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 65. Korea Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 67. India Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 68. Australia Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 69. Germany Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 70. France Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 71. UK Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 72. Italy Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 73. Russia Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 74. Spain Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 77. Israel Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Neoantigen Vaccine Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Neoantigen Vaccine Market Size 2023-2028 ($ Millions)